Varicula Biotec
Developer of an immuno-oncological drug intended to support the repair mechanisms of damaged cells. The company offers a strong immunomodulatory biological with an understanding of the immune system, ...
Valuation
$15.8M
Market implied
Share Price
N/A
Total Raised
$2.9M
Last Round
N/A